Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.
暂无分享,去创建一个
M. Becich | D. Landsittel | R. Dhir | J. Nelson | Y. Yu | Ling Jing | B. Ren | Lijun Liu | C. McDonald | R. Thomas | S. Finkelstein | G. Michalopoulos | Jian-Hua Luo | Baoguo Ren | Courtney McDonald
[1] Bernard R. Rosner,et al. Fundamentals of Biostatistics. , 1992 .
[2] R. H. Myers. Classical and modern regression with applications , 1986 .
[3] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[4] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[6] Y. Pekarsky,et al. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[7] M. Emmert-Buck,et al. Loss of heterozygosity on 8p in prostate cancer implicates a role for dematin in tumor progression. , 1999, Cancer genetics and cytogenetics.
[8] E. Algar,et al. Analysis of CDKN1C in Beckwith Wiedemann Syndrome , 2000, Human mutation.
[9] M. Rubin,et al. Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis. , 2001, Neoplasia.
[10] David Handelsman,et al. Identification of differentially expressed genes in organ‐confined prostate cancer by gene expression array , 2001, The Prostate.
[11] J. Welsh,et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.
[12] S. Dhanasekaran,et al. Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.
[13] M. Bittner,et al. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. , 2001, Cancer research.
[14] D. Pirone,et al. A New Family of Cdc42 Effector Proteins, CEPs, Function in Fibroblast and Epithelial Cell Shape Changes* , 2001, The Journal of Biological Chemistry.
[15] T. Stamey,et al. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. , 2001, The Journal of urology.
[16] G. Muir,et al. Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray , 2001, British Journal of Cancer.
[17] M. Becich,et al. Myopodin, a synaptopodin homologue, is frequently deleted in invasive prostate cancers. , 2001, The American journal of pathology.
[18] M. Bronchud,et al. Is cancer really a 'local' cellular clonal disease? , 2002, Medical hypotheses.
[19] E. Latulippe,et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. , 2002, Cancer research.
[20] Matthias Kretzler,et al. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. , 2002, The American journal of pathology.
[21] E. Lander,et al. Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.
[22] Rajiv Dhir,et al. Gene expression analysis of prostate cancers , 2002, Molecular carcinogenesis.
[23] Alicia Samuels,et al. Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.